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Table [1](#Tab1){ref-type="table"} indicates the prevalence of the symptoms found in our cohort of carriers of the m.3243A\>G mutation. Due to a mistake in the original published article, the prevalences are shown in absolute numbers rather than percentages. A corrected table with the prevalences in percentages is given here.Table 1Signs and symptoms of the m.3243A\>G mutation scored by the NMDAS, sorted by prevalence (n = 71)Signs & SymptomsPrevalence (%)Hearing loss68Gastro-intestinal Symptoms59Decreased Vision59Exercise Intolerance54Glucose Intolerance52Gait Instability51Cerebellar Ataxia49Myopathy48Cognition \<33th percentile45Ptosis45Cardiovascular Involvement44Vision Complaints37Respiratory Muscle Weakness37Problems Dressing34Problems Hygiene34Speech Difficulties31Psychiatric Problems28Migraine Headaches25Neuropathy20Swallowing Difficulties18Dysphonia / Dysarthria17Apraxia13Handwriting Difficulties13Seizures13CPEO7Encephalopatic Episodes6Stroke-like Episodes6Pyramidal Involvement6Extrapiramidal Involvement3

The abstract of the article states the four most prevalent symptoms; hearing loss, gastro-intestinal problems, exercise intolerance and glucose intolerance. But it uses the numbers provided by the wrong table. The abstract with the correct percentages of the four most prevalent symptoms is given here.

**Abstract** The m.3243A\>G mutation has become known as the MELAS mutation. However, many other clinical phenotypes associated with this mutation have been described, most frequently being Maternally Inherited Diabetes and Deafness (MIDD). The m.3243A\>G mutation, can be detected in virtually all tissues, however heteroplasmy differs between samples. Recent reports indicate, a preference to perform mutation analysis in Urinary Epithelial Cells (UEC). To test this, and to study a correlation between the mutational load in different tissues with two mitochondrial scoring systems (NMDAS and NPMDS) we investigated 34 families carrying the m.3243A\>G mutation. Heteroplasmy was determined in three non-invasively collected samples, namely leucocytes, UEC and buccal mucosa. We included 127 patients, of which 82 carried the m.3243A\>G mutation. None of the children (n = 11) had specific complaints. In adults (n = 71), a median NMDAS score of 15 (IQR 10-24) was found. The most prevalent symptoms were hearing loss(68 %), gastro-intestinal problems (59 %), exercise intolerance (54 %) and glucose intolerance (52 %). Ten patients had neurologic involvement. Buccal mucosa had the best correlation with the NMDAS in all adults (r = 0.437, p \< 0.001), whereas UEC had the strongest correlation with the NMDAS in severely affected patients (r = 0.593, p = 0.002). Heteroplasmy declined significantly with increasing age in all three samples (leucocytes r = -0.705 (p \< 0.001), UEC r = -0.374 (p = 0.001), buccal mucosa r = -0.460 (p \< 0.001). In our cohort of 82 patients, the m.3243A\>G mutation causes a wide variety of signs and symptoms, MIDD being far more prevalent than MELAS. Looking at the characteristics of the three non-invasively available tissues for testing heteroplasmy we confirm that UEC are the preferred sample to test.

The prevalences indicated in the results section of the original article are correct.

The online version of the original article can be found at 10.1007/s10545-012-9465-2.
